Protocols

Discontinuation & Taper: Stopping Ketamine Safely

Knowing when to stop is as important as knowing when to start. Ketamine treatment should have an off-ramp from day one.

Written by: Ira ZootMedical review status: Not yet clinically reviewed.Last updated: June 4, 2026Evidence: Clinical practice guidelines; addiction medicine literature

This page has been written and edited by the publisher. It has not been reviewed by a licensed clinician.

Quick answer

Is there a withdrawal syndrome?

Therapeutic-dose ketamine does not produce a classical physiological withdrawal syndrome. Some patients report mood drop or fatigue when stopping — usually reflecting return of underlying depression rather than withdrawal. Recreational high-dose patterns are a different story and carry real dependency risk.

Three reasons to stop

1. Non-response

If you've completed a full induction (6-8 sessions) without meaningful improvement, continuing is unlikely to help. Stopping is the right call. Discuss alternatives — TMS, different medications, intensive therapy.

2. Goal achieved

Sustained remission with stable function over months is the signal to taper maintenance toward zero. Use therapy and lifestyle to consolidate gains.

3. Adverse trajectory

Escalating dose-seeking, urinary symptoms, cognitive complaints, or emerging dependence are all reasons to stop. Honest reporting to your prescriber is essential.

How to taper maintenance

Extend interval gradually (e.g., monthly → 6-week → quarterly → as-needed).
Reduce per-session dose in parallel where appropriate.
Increase therapy and lifestyle support during the taper window.
Monitor symptoms weekly with a validated scale (PHQ-9, GAD-7).

Watch for recreational drift

At-home or telehealth ketamine prescribed without close monitoring can drift into recreational use patterns. Warning signs: requesting higher doses, using outside prescribed schedule, hiding use from prescriber. Bring these patterns to your provider immediately.

After stopping

Maintain therapy, sleep, exercise, and connection. Symptom recurrence is not failure — it's information. Many patients return for a short re-induction months or years later and respond well again.

About the author

Ira Zoot

Publisher and editor of Ketalux, based in Chicago, Illinois. Ira is a ketamine therapy patient, not a clinician. This is editorial review, not medical review: Ira is not a licensed clinician and does not provide diagnosis or medical care. Ketalux does not accept compensation from providers in exchange for favorable editorial coverage, evidence ratings, recommendations, patient referrals, or organic provider ranking. Read the full publisher disclosure →

Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.